Amit Munshi is the CEO of Orna Therapeutics, a pioneering company in the field of RNA therapeutics. With over 30 years of industry experience, Munshi has previously led Arena Pharmaceuticals to significant growth and a major acquisition by Pfizer. At Orna, he is focused on advancing innovative RNA-centric approaches to reshape the future of medicine.
Amit Munshi's Email & LinkedIn
You can also contact Amit Munshi through his LinkedIn.
If you want to find further information about Amit Munshi, like his phone number, or other people working at Orna Therapeutics, sign up to Clay.
Who is the CEO of Orna Therapeutics?
With a robust career spanning over three decades, Amit Munshi has established himself as a prominent figure in the biotechnology industry. Currently serving as the CEO of Orna Therapeutics, Munshi is steering the company towards groundbreaking advancements in RNA therapeutics. His extensive experience includes leading Arena Pharmaceuticals to notable growth and a significant acquisition by Pfizer.
At Orna, he is leveraging his expertise to drive the development of innovative RNA-centric approaches, aiming to revolutionize the future of medicine.
Work History
Amit Munshi's extensive work history includes a variety of leadership roles across numerous companies in the biotechnology and pharmaceutical industries. Here is a detailed list of his previous positions:
- Orna Therapeutics - Chief Executive Officer (2024 - Present)
- Zura Bio Limited (Nasdaq: ZURA) - Chairman (2023 - Present)
- Enterprise Therapeutics - Chairman, Board of Directors (2020 - Present)
- Galecto, Inc. - Member Board Of Directors (2020 - Present)
- Oxeia Biopharmaceuticals - Co-Founder (2014 - Present)
- ReNAgade Therapeutics - Chief Executive Officer & President (2023 - 2024)
- Arena Pharmaceuticals, Inc. - President and Chief Executive Officer (2016 - 2022)
- Pulmatrix Inc. - Board Member (2017 - 2021)
- Cytrellis Biosystems, Inc. - Board Member (2016 - 2019)
- Epirus Biopharmaceuticals, Inc - President and CEO (2012 - 2016)
- Cynvenio Biosystems, Inc. - Board Member (2011 - 2014)
- Percivia LLC - President & CEO (2011 - 2012)
- KYTHERA Biopharmaceuticals - Co-Founder & Chief Business Officer (2005 - 2011)
- Amgen - Sr Director/GM European Nephrology Business Unit (1997 - 2005)
- Astra Merck - Marketing Manager (1994 - 1997)
- IOLAB (division of Johnson & Johnson) - Marketing (1990 - 1994)
Education History
Amit Munshi's educational journey began at the University of California, Riverside, where he earned a Bachelor of Arts degree, majoring in History and Economics, from 1986 to 1990. Following his undergraduate studies, Munshi pursued an MBA at the Drucker School of Management, completing the program between 1991 and 1993. This solid academic foundation has undoubtedly contributed to his successful career in the biotechnology and pharmaceutical industries.
When did Amit Munshi join Orna Therapeutics?
Joining Orna Therapeutics on May 1, 2024, Amit Munshi took on the role of Chief Executive Officer. With this new position, Munshi has been at the helm of Orna Therapeutics for a relatively short period, yet his extensive experience in the biotechnology industry positions him well to lead the company towards innovative advancements in RNA therapeutics. His leadership is expected to drive the company's mission forward, leveraging his deep industry knowledge and strategic vision.